Home・Aandelen Lijst・AngioDynamics Inc

AngioDynamics Inc

Open

SectorGezondheidszorg

16.03 1.2

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

15.54

Max

16.02

Belangrijke statistieken
By Trading Economics
Inkomsten	-3.3M -11M
Verkoop	8.2M 87M
EPS	-0.07
Winstmarge	-13.169
Werknemers	632
EBITDA	-26M -28M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+32.49% upside

Dividenden
By Acuity
Volgende Winsten	1 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	123M 652M
Vorige openingsprijs	14.83
Vorige sluitingsprijs	16.03

Nieuwssentiment

By Acuity

67%

33%

292 / 340 Rangschikking in Healthcare

AngioDynamics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 aug 2026, 20:08 UTC

AngioDynamics Inc shares are lower as the Health Care Equipment sub-sector declines. The overall market also closed lower during Wednesday's trading session.

24 aug 2026, 19:56 UTC

News

AngioDynamics Inc is lower today, continuing a trend of declines amid broader market pressures from recent geopolitical tensions affecting economic uncertainty.

18 aug 2026, 19:16 UTC

AngioDynamics Inc is trading higher, reaching a notable intraday high. The stock remains above its 20-day moving average amid a supportive market environment.

17 aug 2026, 19:41 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

13 aug 2026, 20:01 UTC

AngioDynamics Inc shares are lower today, reflecting a slight decline since Wednesday's close. The stock peaked earlier in the session before pulling back.

12 aug 2026, 22:02 UTC

AngioDynamics Inc shares are lower in after-market hours, with no specific news identified to explain the decline. They remain below their 20-day moving average.

11 aug 2026, 19:51 UTC

AngioDynamics Inc shares are higher today, driven by a significant upward trend in the Health Care Equipment sub-sector, remaining above the 20-day moving average.

10 aug 2026, 19:36 UTC

AngioDynamics Inc shares are higher since Friday's close, despite earlier declines. Broader market volatility may be influenced by fluctuations in oil prices.

7 aug 2026, 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

6 aug 2026, 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

5 aug 2026, 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

4 aug 2026, 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

3 aug 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31 jul 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30 jul 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29 jul 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28 jul 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27 jul 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24 jul 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23 jul 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22 jul 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21 jul 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 jul 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Peer Vergelijking

Prijswijziging

AngioDynamics Inc Prognose

Koersdoel

By TipRanks

32.49% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 21 USD 32.49%

Hoogste 24 USD

Laagste 19 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor AngioDynamics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan AngioDynamics Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

292 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.